-
Orsted shelves North Sea wind project
14:34 Wednesday 07 May 2025
-
FTSE 250 movers: Victrex surges on contract win; Trainline hits buffers
14:19 Wednesday 07 May 2025
-
Europe midday: Shares lower ahead of Fed decision
13:35 Wednesday 07 May 2025
-
Trainline shares slide on caution over sales growth, TfL plans
13:30 Wednesday 07 May 2025
-
BMW forecasts tariff regime will ease from summer, shares spark
13:18 Wednesday 07 May 2025
-
US pre-open: Futures higher as investors digest trade news
12:45 Wednesday 07 May 2025
-
FD Technologies in 'advanced' takeover talks with TA Associates
12:38 Wednesday 07 May 2025
-
London midday: FTSE rally loses steam as pharma, telecoms stocks fall
12:33 Wednesday 07 May 2025
(Sharecast News) - The FTSE 100 was on track to snap a 16-day winning streak on Wednesday as investors showed caution ahead of a central bank meeting in the US, with heavy losses in the telecoms and pharma sectors weighing on the index.
-
Franchise Brands trading shows signs of improvement in Q1
12:33 Wednesday 07 May 2025
-
Redcentric reports solid full-year trading performance
12:26 Wednesday 07 May 2025
-
Andrews Sykes reports record operating profit
12:18 Wednesday 07 May 2025
-
SigmaRoc updates long-term financial targets
12:09 Wednesday 07 May 2025
-
Kitwave trades as expected through first half
12:05 Wednesday 07 May 2025
-
AVI urges investee Wacom to make governance changes
11:57 Wednesday 07 May 2025
(Sharecast News) - Asset Value Investors (AVI), the investment manager behind FTSE 250-listed AVI Global Trust, launched a public campaign on Wednesday calling on Wacom Corporation to implement governance and strategic changes aimed at improving long-term corporate value.
-
Rentokil chief Andy Ransom to retire
11:52 Wednesday 07 May 2025
-
London open: Stocks down as trade and geopolitics overshadow Fed meet
11:50 Wednesday 07 May 2025
-
Tritax Big Box reports strong occupational demand
11:48 Wednesday 07 May 2025
-
Victrex's Magma programme progresses with Petrobras contract
11:41 Wednesday 07 May 2025
-
Syncona firm Beacon reports encouraging gene therapy trial results
11:36 Wednesday 07 May 2025
(Sharecast News) - Syncona said in an update on Wednesday that its portfolio company Beacon Therapeutics has reported encouraging six-month interim results from its phase two 'DAWN' trial, marking a key milestone in the development of its gene therapy candidate for X-linked retinitis pigmentosa (XLRP).
-
GSK, AstraZeneca slide after FDA unveils new vaccine lead
11:32 Wednesday 07 May 2025
-
Novo Nordisk cuts guidance but says generic competition will ease
11:24 Wednesday 07 May 2025
-
Asia report: Markets rise on hopes for US-China trade talks
11:17 Wednesday 07 May 2025
-
UK construction sector remains under pressure - PMI
10:44 Wednesday 07 May 2025
-
RHI Magnesita Q1 sales fall, downside risks increase
10:43 Wednesday 07 May 2025
(Sharecast News) - Refractory products supplier RHI Magnesita said both sales and margins had fallen in Q1 as downside risks to its FY25 trading outlook increased, driven by a weak outlook for H1 performance and rising global trade tensions, all of which could negatively affect end markets.
-
Eurozone retail sales unexpectedly fall
10:38 Wednesday 07 May 2025
-
Spirent Communications 'tracking to plan' after Q1 performance
10:03 Wednesday 07 May 2025
-
Vodafone finance director to step down by early 2026
10:02 Wednesday 07 May 2025
-
BAE Systems maintains guidance amid solid trading
10:00 Wednesday 07 May 2025
-
Eurozone construction sees modest uptick but outlook remains 'bleak'
09:46 Wednesday 07 May 2025
-
AstraZeneca receives 'positive high-level results' results from Enhertu trial
09:23 Wednesday 07 May 2025
(Sharecast News) - Drugmaker AstraZeneca revealed on Wednesday that it had received "positive high-level results" from a Phase III trial on its specifically engineered HER2-directed DXd antibody drug conjugate Enhertu.
Popular News
You are here: news > news pulse
10 Lower Thames St,
London EC3R 6EN